Extended Course of Maraviroc, a CCR5 Antagonist, Is Safe and Effective in Graft-Versus-Host Disease Prophylaxis. Final Results of a Phase II Study

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.652

Related search